Study Summary
This trial evaluates if a new drug is better than current treatments for advanced melanoma.
- Advanced Melanoma
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: from first dose to approximately 2 years
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
Arm A
1 of 3
Arm B
1 of 3
Arm C
1 of 3
Experimental Treatment
460 Total Participants · 3 Treatment Groups
Primary Treatment: Arm A · No Placebo Group · Phase 2 & 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there still available spots in this exploration of treatments?
"As published on clinicaltrials.gov, this research is actively searching for suitable candidates. The trial was posted in December of 2022 and the information has been updated as recently as February 2021." - Anonymous Online Contributor
What is the scope of recruitment for this research endeavor?
"Affirmative. The research posted on clinicaltrials.gov reveals that this medical trial is actively looking for applicants, with the initial posting being on December 19th 2022 and an update occurring as recently as February 21st 2023. 460 participants must be enrolled from 2 different sites." - Anonymous Online Contributor